Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
discovered that the toxin induces DNA damage responses in cultured cells that activates a senescence tumour suppressor mechanism ( https://doi.org/10.1038/s41467-019-12064-1 ). Cells undergoing toxin
-
Department and School: Yale School of Medicine, Department of Neurology Anticipated Appointment Dates: July 2026 Email/Website: [email protected] , https://medicine.yale.edu/lab/tumor-neuroimmunology-lab
-
) for image-guided (PET/SPECT, CT, MRI, optical, etc.) therapeutic applications (radiotherapy, immunotherapy, phototherapy, etc.). Investigate mechanisms at the nano-bio interface to better modulate
-
radiotherapy equipment. Knowledge of radioactive sources used for brachytherapy. Knowledge of radiation safety applied to radiotherapy and general outpatient environment. Familiarity with operation of
-
George Washington University | Washington, District of Columbia | United States | about 17 hours ago
treated with radiotherapy; teaching students and residents in the classroom and clinical settings; and developing an active research program. Opportunities are available to participate in ongoing
-
radiotherapy to induce immunogenic cell death and enhance the effectiveness of immune checkpoint inhibitors. In parallel, the consortium is advancing state-of-the-art PET and MRI methodologies for
-
radiotherapy. Investigate mechanisms of action and therapeutic response using molecular and cellular biology, flow cytometry and gene-editing approaches. Support translational drug development
-
biomimetic breast-on-a-chip platforms for the study of personalized radiotherapy in breast cancer. The fellow will contribute to: (i) familiarization with the 3D microenvironments developed in the
-
will be doing: Evaluate novel hypoxia-selective therapeutics using 2D and 3D cancer models, including in combination with chemotherapy and radiotherapy. Investigate mechanisms of action and
-
will be doing: Evaluate novel hypoxia-selective therapeutics using 2D and 3D cancer models, including in combination with chemotherapy and radiotherapy. Investigate mechanisms of action and